The full report on “Strengthening the Legal Environment for the Elimination of Falsified and Substandard Medicines” is now available. The report is the third product of the pilot and preliminary phase of a larger initiative to build a knowledge base and collection of tools to support a whole-of-government approach to manage the public health problem of falsified and substandard (FS) medicines in any country. See also the executive summary from the beginning stages of this initiative.
The initiative is designed to provide the pilot country, Uganda, with guidance on steps it can take to address the problem of FS medicines within its borders and with its neighbors. Also as a result of this initiative, an assessment tool and guide to developing a national strategy to address FS medicines were also developed (see below), which will be further tested and refined as this project continues, for future use in other jurisdictions.
The project takes into account not only national but also cross border and regional solutions, as exemplified by the initiatives of the East African Community (EAC). The project was financed with support from the World Bank through the Global Forum on Law, Justice and Development.
The initiative was jointly conceived and coordinated by four organizations: the World Bank, the International Development Law Organization (IDLO), the O'Neill Institute for National and Global Health Law at Georgetown University, and the United Nations Interregional Crime and Justice Research Institute (UNICRI). The National Drug Authority of the Government of Uganda partnered with the four organizations to ensure a successful pilot.